A comprehensive international study reveals that delayed or altered maturation of the infant gut microbiome may triple the risk of developing type 1 diabetes, opening potential avenues for early screening and intervention.
A large international study published in Nature Metabolism suggests that the pace at which a child’s gut microbiome matures in the first years of life may help shape the risk of type 1 diabetes, particularly in those already carrying a strong inherited risk. The prospective research followed 887 children in Finland, Germany, Sweden and the United States and analysed more than 12,000 stool samples collected over six years to track how their gut bacteria changed over time.
The team identified three broad microbiome patterns: early-matured, late-matured and early-plateaued. Children in the early-matured group showed rapid change during infancy, with rising bacterial diversity and a shift towards microbes better suited to digesting fibre after solid food was introduced. By contrast, children in the early-plateaued group lagged behind, with less diverse gut communities that remained dominated by organisms adapted to milk sugars. Those children faced roughly three times the risk of developing type 1 diabetes, or the auto-immune process that precedes it, compared with peers whose microbiomes developed more typically.
The findings add to a growing body of work linking gut microbes and diabetes biology, although they do not prove cause and effect. A separate study in Nature Communications found that children with new-onset type 1 diabetes had lower butyrate production and altered bile acid metabolism, alongside changes consistent with greater inflammatory potential in the gut. Earlier research has also shown that the infant gut microbiome starts out relatively low in diversity before becoming more adult-like during the first two years of life, with factors such as delivery method helping to shape that transition.
The Nature Metabolism paper also suggests that genetics may influence how strongly microbiome development relates to diabetes risk. Certain variants involved in antimicrobial and antiviral immune responses appeared to modify the association, although the elevated risk linked to early microbiome stagnation was seen across genetic groups. Researchers say the next step is to test whether microbiome-based screening or interventions could eventually help identify children at highest risk, but they caution that larger trials will be needed before any clinical use.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
